Cronos

Cronos

Pharmaceuticals
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

$1.2B

Market Cap • 9/15/2026

2012

(14 years)

Founded

2016

(10 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Canada

Canada

Country

Valuation

P/B

1,1

P/S

6,6

P/EBITDA

107,4

P/OCF

19,6

P/FCF

23,7

P/E

16

BVPS

2,8

EPS

0,2

Market Cap

Market Cap

1,2B

EV

432M

EV/Revenue

2,4

EV/EBITDA

39,4

EV/EBIT

-130,4

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

3,3%

Total Yield

3,3%

Payout

0%

Retained Earnings

492,3M

Profitability

Gross Margin

45,9%

EBITDA Margin

6,1%

EBIT Margin

Net Margin

44,2%

D&A/EBITDA

14,2%

R&D/Revenue

3%

Capex/Revenue

5,7%

Capex/D&A

71,6%

Capex/OCF

17%

SBC/OCF

10,7%

% PPE

12,1%

% Goodwill

5,4%

ROE

7%

ROIC

Growth

CAGR Revenue 5Y

25,9%

CAGR Op. Income 5Y

-62,8%

Leverage

N.D./EBITDA

Debt/Equity

0%

Current Ratio

16,2

Quick Ratio

15,2

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium